A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IgAN / immunoglobulin A nephropathy

[Related PubMed/MEDLINE]
Total Number of Papers: 536
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IgAN  (>> Co-occurring Abbreviation)
Long Form:   immunoglobulin A nephropathy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A Functional Variant rs3093023 in CCR6 Is Associated With IgA Nephropathy by Regulating Th17 Cells in a North Han Chinese Population. CCR6, eQTL, OR
2021 Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis. BCI, eGFR, GFR
2021 Associations of Genetic Variants Contributing to Gut Microbiota Composition in Immunoglobin A Nephropathy. Gd-IgA1, GWAS, QTL
2021 Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection. CI, HBV, HR
2021 Complement and kidney disease, new insights. C3G, FHR5, MMF
2021 Comprehensive metabolomic profiling in early IgA nephropathy patients reveals urine glycine as a prognostic biomarker. cNRI, hTECs
2021 Differential expression analysis of urinary exosomal circular RNAs in patients with IgA nephropathy. circRNA, DECs, GO, HCs, KEGG, PI3K-Akt
2021 Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis. CIs, ESRD, HCQ, MMF, RCTs, RRs, SAEs, TAC
2021 Glomerular Complement Factor H-Related Protein 5 is Associated with Histologic Injury in Immunoglobulin A Nephropathy. FHR-5
10  2021 Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective. BMI, CKD, eGFR, F/B, OTU
11  2021 Health-related quality of life in children with immunoglobulin A nephropathy - results of a multicentre national study. HRQoL
12  2021 Hematuria was a high risk for renal progression and ESRD in immunoglobulin a nephropathy: a systematic review and meta-analysis. ESRD, RRs
13  2021 Identification of a novel interplay between intestinal bacteria and metabolites in Chinese patients with IgA nephropathy via integrated microbiome and metabolome approaches. ---
14  2021 IgA nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review. eGFR, IBD
15  2021 Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study. eGFR, ESKD, GCLs
16  2021 Immunoglobulin A nephropathy and ischemic heart disease: a nationwide population-based cohort study. ESRD, HRs, IHD
17  2021 Integrated Fecal Microbiome and Serum Metabolomics Analysis Reveals Abnormal Changes in Rats with Immunoglobulin A Nephropathy and the Intervention Effect of Zhen Wu Tang. ---
18  2021 Kidney microRNA-21 Expression and Kidney Function in IgA Nephropathy. miR-21
19  2021 Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With Stage 3 or 4 CKD: A Retrospective Cohort Study. USC
20  2021 Mesangial IgM deposition predicts renal outcome in patients with IgA nephropathy: a multicenter, observational study. CR, ESRD, PSM
21  2021 Overlapping obesity-related glomerulopathy and immunoglobulin A nephropathy: clinical and pathologic characteristics and prognosis. BMI, O-FSGS, ORG
22  2021 Periostin Contributes to Immunoglobulin a Nephropathy by Promoting the Proliferation of Mesangial Cells: A Weighted Gene Correlation Network Analysis. eGFR, MMCs, PCNA, POSTN, WGCNA
23  2021 Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy. KEGG, PICRUSt
24  2021 Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study. aORs, CI, SGA
25  2021 Quantitative proteomics analysis of lysine 2-hydroxyisobutyrylation in IgA nephropathy. ---
26  2021 Reduction in proteinuria after immunosuppressive therapy and long-term kidney outcomes in patients with immunoglobulin A nephropathy. eGFR, HRs
27  2021 Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy. IFN-gamma, IL, MCP, mRNA, PBMCs, Th
28  2021 Spatiotemporal trends and prognosis of end-stage renal disease patients with biopsy-proven immunoglobulin A nephropathy in France from 2010 to 2014. ADPKD, CI, ESRD, GN, PD
29  2021 Streptococcus mutans induces IgA nephropathy-like glomerulonephritis in rats with severe dental caries. ---
30  2021 The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy. CTSS, ELISA, HMCs
31  2021 Tubular decoy receptor 2 as a predictor of prognosis in patients with immunoglobulin A nephropathy. DcR2, eGFR, RTECs, T lesion
32  2021 Utility of remission criteria for the renal prognosis of IgA nephropathy. NR
33  2020 A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy. HC, MN
34  2020 Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy. IgH, RT
35  2020 Analysis of microbial changes in the tonsillar formalin-fixed paraffin-embedded tissue of Chinese patients with IgA nephropathy. CT, ESRD, FFPE, PCOA, ROC, rRNA, WS
36  2020 Anaphylatoxins enhance Th9 cell recruitment via the CCL20-CCR6 axis in IgA nephropathy. HMCs, IHC, IL, PBMCs, Th, Treg, WT
37  2020 Arteriolar C4d in IgA Nephropathy: A Cohort Study. ---
38  2020 Autoimmune hepatitis in a patient with immunoglobulin A nephropathy: A case report. AIH
39  2020 Bioinformatics analysis reveals novel hub gene pathways associated with IgA nephropathy. BiNGO, DEGs, GO, ITGB2, PPI
40  2020 Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy. CD, IBD, UC
41  2020 Co-delivery of p38alpha MAPK and p65 siRNA by novel liposomal glomerulus-targeting nano carriers for effective immunoglobulin a nephropathy treatment. ---
42  2020 Coagulation parameters are associated with the prognosis of immunoglobulin a nephropathy: a retrospective study. APTT, eGFR, ESRD, PT
43  2020 Comparative analysis of the tonsillar microbiota in IgA nephropathy and other glomerular diseases. ---
44  2020 Comparison of clinicopathological features and prognosis between IgA nephropathy and purpura nephritis in adults with diffuse endocapillary proliferation: a single-center cohort study. DEP, HSPN
45  2020 Comprehensive analysis of circRNA expression profiles and circRNA-associated competing endogenous RNA networks in IgA nephropathy. ceRNA, circRNAs, DEcircRNAs, DEmiRNAs, DEmRNAs, GEO, miRNAs, mRNAs, PBMCs, PPI, qRT-PCR, SEC24C, STRING
46  2020 Corticosteroids Improve Renal Survival: A Retrospective Analysis From Chinese Patients With Early-Stage IgA Nephropathy. CR, CS, eGFR, ESRD, IT, PR, SC, SC
47  2020 Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria. CR, eGFR, ESRD, IT, PR, RASi, SC
48  2020 Crescentic IgA nephropathy after administration of human monoclonal interleukin-12/23p40 antibody in a patient with Crohn's disease: a case report. CD, Gd-IgA1, IL, UST
49  2020 Crescents formations are independently associated with higher mortality in biopsy-confirmed immunoglobulin A nephropathy. ---
50  2020 Derivation of an induced pluripotent stem cell line (GWCMCi001-A) from PBMCs of a four-year-old male patient with Immunoglobulin A nephropathy. ---
51  2020 Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy. ESKD
52  2020 Effectiveness of Qingre Lishi Yishen decoction on the glomerular fibrosis of immunoglobulin A nephropathy in a rat's model. BSA, FN, LPS, QRLS, TNF-alpha, VAL
53  2020 Estrogen receptor alpha expression in renal tissue and its relationship with prognosis in immunoglobulin A nephropathy. eGFR, ERalpha, SCr
54  2020 Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study. eGFR, UACR
55  2020 Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy. CI, ESRD, HR
56  2020 Glomerulonephritis Histopathological Pattern Change. AKI, CKD, ESKD, GN, MCD
57  2020 High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients. HSs, PBs, TNF
58  2020 Hypertension/prehypertension and its determinants in pediatric IgA nephropathy. HT, preHT
59  2020 Identification of differentially expressed circulating exosomal lncRNAs in IgA nephropathy patients. lncRNAs, qRT-PCR
60  2020 Identification of glomerular lesions and intrinsic glomerular cell types in kidney diseases via deep learning. ARPS, CI, PAS
61  2020 IgA Nephropathy: An Interesting Autoimmune Kidney Disease. ---
62  2020 Mass spectrometry-based screening identifies circulating immunoglobulinA-α1-microglobulin complex as potential biomarker in immunoglobulin A nephropathy. CICs, eGFR
63  2020 MicroRNA-27a-3p directly targets FosB to regulate cell proliferation, apoptosis, and inflammation responses in immunoglobulin a nephropathy. miRNA, MTT
64  2020 MicroRNA‑196b targets COSMC in pediatric IgA nephropathy. miRNAs
65  2020 Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population. Gd-IgA1, HCs, ICAM-1, LBP, sCD14, TNF-alpha
66  2020 Patterns in renal diseases diagnosed by kidney biopsy: A single-center experience. MCD, MN
67  2020 Pediatric glomerular hematuria: a clinicopathological study. AS, GBMT, TBMD
68  2020 Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study. ---
69  2020 Preventive Effect of Tonsillectomy on Recurrence of Henoch-Schonlein Purpura Nephritis after Intravenous Methylprednisolone Pulse Therapy. HSP, HSPN, IVMP
70  2020 Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy. GN
71  2020 Relationship between serum C3/C4 ratio and prognosis of immunoglobulin A nephropathy based on propensity score matching. 24 h Upre, ESRD, SCr
72  2020 Remission of Proteinuria May Protect against Progression to Chronic Kidney Disease in Pediatric-Onset IgA Nephropathy. CKD
73  2020 Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions. ---
74  2020 Research on the Application Value of Serum and Urine beta2-Microglobulin in Immunoglobulin a Nephropathy. ---
75  2020 Retrospective Analysis of Clinical Outcomes in Patients with Immunoglobulin A Nephropathy and Persistent Hematuria Following Renin-Angiotensin System Blockade. eGFR, RASB
76  2020 SGLT2 inhibition requires reconsideration of fundamental paradigms in chronic kidney disease, 'diabetic nephropathy', IgA nephropathy and podocytopathies with FSGS lesions. CKD, DAPA-CKD, SGLT2
77  2020 Shear wave elastography findings in Immunoglobulin A Nephropathy patients: is it more specific and sensitive for interstitial fibrosis or interstitial fibrosis/tubular atrophy? IF, IFTA, PPV, SWE, YM
78  2020 sPLA2-IB Level Correlates with Hyperlipidemia and the Prognosis of Idiopathic Membranous Nephropathy. HDL-C, IMN, LDL-C, sPLA2-IB
79  2020 ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome. Gd-IgA1, GWAS, rST6Gal1
80  2020 T lymphocytes in IgA nephropathy. Gd-IgA1
81  2020 Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A. IL-17A, UUO
82  2020 The Characteristics of Intestinal-Barrier Damage in Rats With IgA Nephropathy. D-LA, DAO, MUC2, NC, OCLN, SD, ZO-1
83  2020 The Effects of Hyperuricemia on the Prognosis of IgA Nephropathy are More Potent in Females. CI, HR
84  2020 The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis. CENTRAL, CIs, ESRD, RRs, SUCRA
85  2020 The prognostic value of platelet-to-lymphocyte ratio on the long-term renal survival in patients with IgA nephropathy. eGFR, MAP, PLR
86  2020 The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin Anephropathy and associated with defective CD46 expression. eGFR, iPS, LMP2, MECL1, mRNAs, TLR, VALIGA
87  2020 Tonsillectomy Monotherapy for IgA Nephropathy: A Case Series. eGFR
88  2020 Upregulation of microRNA‑140‑3p mediates dachshund family transcription factor 1 expression in immunoglobulin A nephropathy through cell cycle‑dependent mechanisms. DACH1, HMCs, miRNAs, pIgA
89  2020 Urinary cMet as a prognostic marker in immunoglobulin A nephropathy. cMet Ab, CR, TNF, ucMet
90  2020 Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-kappaB/NLRP3 Pathway. HMC, ZWT
91  2020 [Renal pathological characteristics in cirrhotic patients]. ---
92  2019 3'UTR SNPs in the LPP gene associated with Immunoglobulin A nephropathy risk in the Chinese Han population. CIs, LPP, ORs, SNPs
93  2019 3'UTR variants of TNS3, PHLDB1, NTN4, and GNG2 genes are associated with IgA nephropathy risk in Chinese Han population. 3'UTR, SNP
94  2019 A Case of Essential Thrombocythemia and IgA Nephropathy with Literature Review of the Concurrence. ET, PDGF
95  2019 A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity. AUC, Cr, DB, FIB, IgA, IgG, ROC, TC, TP, UN
96  2019 Adalimumab-induced IgA nephropathy. CD, TNF-alpha
97  2019 An Exome Sequencing Study of 10 Families with IgA Nephropathy. VUS, WES
98  2019 Association between the ACYP2 Polymorphisms and IgAN Risk in the Chinese Han Population. ACYP2, CI, OR, SNPs
99  2019 Clinical Significance of Crescent Formation in IgA Nephropathy - a Multicenter Validation Study. eGFR, ESRD
100  2019 Clinical significance of urinary tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in immunoglobulin A nephropathy